DigiPath Receives Nevada State Approval for Cannabis Testing Lab in Las Vegas
LAS VEGAS, Nov. 6, 2014 /PRNewswire/ -- DigiPath, Inc. (OTCBB andOTCQB: DIGP), an independent cannabis testing and media firm, announced today that it has received approval from the State of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas, Nevada.
DigiPath Labs is in the process of applying for construction permits, ordering equipment, and hiring staff in anticipation of opening the Cameron Street laboratory. To expedite construction, the company is working with a local architectural firm it engaged during the application process. The lab is expected to open its doors to customers in early 2015.
"We are grateful to the State of Nevada for helping to advance our goal of setting a new benchmark for medical cannabis testing and safety screening," said Todd Denkin, CEO of DigiPath, Inc.
"DigiPath Labs is dedicated to increasing transparency of the ingredients inside cannabis-based products. We believe that this information will benefit patients and dispensaries by providing them with important information regarding the products being sold for consumption."
DigiPath Labs will screen medicinal cannabis for potentially harmful contaminants, including:
- Solvents
- Pesticides
- Mold
- Heavy metals, including mercury, arsenic, lead, and cadmium
- Biological toxins, such as aflatoxin, ricin, and botulinum toxins
- Residual organic chemicals used in extraction
- Microbial contaminants including E. coli, salmonella, and Aspergillus
DigiPath Labs will also test cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.
"Patient safety starts with adhering to standardized, rigorous analytical techniques," said Dr. Cindy Orser, Chief Science Officer of DigiPath, Inc. "We believe we have developed best-in-class procedures to test dried plant material and byproducts from the cannabis plant for potency and contaminants."
About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the cannabis industry. Our four business units are DigiPath Labs, TNMNews, Corp., DigiPath Corp., and DigiPath University.
About DigiPath Labs
DigiPath Labs plans to set the industry standard for potency and safety testing of all forms of cannabis-based products using FDA-compliant laboratory equipment. The company is currently working to establish a testing lab in Las Vegas, Nevada and exploring opportunities in other legal states.
For more information, please visit www.digipath.com.
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the in demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. An example of such forward looking statements in this press release includes statements regarding the Company expansion into the botanical, nutraceutical and cannabis industries. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
DigiPath, Inc.
Investor Relations
(888) 552-4440
[email protected]
Logo - http://photos.prnewswire.com/prnh/20140605/94753
SOURCE DigiPath, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article